As of May 04
| -2.97 / -7.77%|
The 10 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 56.50, with a high estimate of 88.00 and a low estimate of 12.00. The median estimate represents a +60.28% increase from the last price of 35.25.
The current consensus among 13 polled investment analysts is to Buy stock in Ionis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.